Interferon for treatment: the dust settles.
作者信息
Galvani D, Griffiths S D, Cawley J C
机构信息
University Department of Haematology, Royal Liverpool Hospital.
出版信息
Br Med J (Clin Res Ed). 1988 Jun 4;296(6636):1554-6. doi: 10.1136/bmj.296.6636.1554.
Abstract
摘要
相似文献
1
Interferon for treatment: the dust settles.用于治疗的干扰素：尘埃落定。
Br Med J (Clin Res Ed). 1988 Jun 4;296(6636):1554-6. doi: 10.1136/bmj.296.6636.1554.
2
[Interferon in the treatment of viral, neoplastic and immunologic diseases].
Patol Pol. 1984 Jul-Sep;35(3):245-61.
3
Interferons in cancer therapy: a reappraisal.癌症治疗中的干扰素：重新评估
Lancet. 1987 Aug 8;2(8554):317-9. doi: 10.1016/s0140-6736(87)90901-9.
4
[Therapeutic use of interferon: current trends and prospects].[干扰素的治疗用途：当前趋势与前景]
Medicina (Firenze). 1990 Apr-Jun;10(2):201-11.
5
[Interferon--properties and action].[干扰素——特性与作用]
Wiad Lek. 1989;42(19-21):1086-91.
6
[The antineoplastic effect of interferon].[干扰素的抗肿瘤作用]
Ugeskr Laeger. 1986 Feb 10;148(7):375-7.
7
[Interferon: validity, risks, prospects of clinical use].
Epidemiol Prev. 1987 Mar;9(30):13-5.
8
Interferons: not just alpha.干扰素：不仅仅是α干扰素。
Cancer Treat Rep. 1986 Dec;70(12):1353-5.
9
Interferon.干扰素
Am J Nurs. 1987 Apr;87(4):459-65.
10
Biologicals for cancer treatment: interferons.用于癌症治疗的生物制品：干扰素。
Hosp Pract (Off Ed). 1985 Dec 15;20(12):71-4, 78-81, 85-6 passim. doi: 10.1080/21548331.1985.11703206.
引用本文的文献
1
Type I interferon and interferon-stimulated gene expression in oral epithelial cells.口腔上皮细胞中的 I 型干扰素和干扰素刺激基因表达。
Mol Oral Microbiol. 2019 Dec;34(6):245-253. doi: 10.1111/omi.12270. Epub 2019 Oct 21.
2
Clinical decisions in the management of the cardiomyopathies.心肌病治疗中的临床决策
Drugs. 1989 Dec;38(6):988-99. doi: 10.2165/00003495-198938060-00009.
3
Cytokines: biological function and clinical use.细胞因子：生物学功能与临床应用
J R Coll Physicians Lond. 1988 Oct;22(4):226-31.
4
Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study.重组人干扰素γ治疗类风湿关节炎：双盲安慰剂对照研究。
Ann Rheum Dis. 1992 Sep;51(9):1039-43. doi: 10.1136/ard.51.9.1039.
本文引用的文献
1
Interferon and laryngeal papillomatosis. The Iowa experience.干扰素与喉乳头状瘤病。爱荷华州的经验。
Ann Otol Rhinol Laryngol. 1983 Jan-Feb;92(1 Pt 1):2-7. doi: 10.1177/000348948309200102.
2
A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.重组白细胞A干扰素在癌症患者中的多剂量I期试验。
JAMA. 1982 Nov 19;248(19):2461-6.
3
Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2.接受重组干扰素α-2治疗的癌症患者骨髓的变化。
Am J Med. 1984 Apr;76(4):593-6. doi: 10.1016/0002-9343(84)90282-1.
4
Alpha interferon for induction of remission in hairy-cell leukemia.α干扰素用于毛细胞白血病的缓解诱导
N Engl J Med. 1984 Jan 5;310(1):15-8. doi: 10.1056/NEJM198401053100104.
5
6
7
Increased levels of interferon-induced (2'--5') oligo-isoadenylate synthetase in mature T-lymphocytes and in differentiated Friend-erythroleukemic cells.成熟T淋巴细胞和分化的Friend红白血病细胞中干扰素诱导的（2'-5'）寡聚异腺苷酸合成酶水平升高。
J Interferon Res. 1981;1(4):559-69. doi: 10.1089/jir.1981.1.559.
8
Adjuvant interferon treatment of human osteosarcoma.人骨肉瘤的辅助性干扰素治疗
Recent Results Cancer Res. 1982;80:103-7. doi: 10.1007/978-3-642-81685-7_17.
9
Application of human leucocyte interferon in patients with carcinoma of the uterine cervix.人白细胞干扰素在子宫颈癌患者中的应用。
Lancet. 1981 May 9;1(8228):1027-30. doi: 10.1016/s0140-6736(81)92190-5.
10
Differential effect of interferon on DNA synthesis, 2-deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumor promotors.干扰素对多肽生长因子和肿瘤促进剂刺激的3T3细胞中DNA合成、2-脱氧葡萄糖摄取及鸟氨酸脱羧酶活性的差异作用。
J Cell Physiol. 1980 Jul;104(1):1-9. doi: 10.1002/jcp.1041040102.
Zotero 插件